The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy
Open Access
- 8 November 2012
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 11 (1), 124-131
- https://doi.org/10.1111/jth.12060
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9BMJ, 2011
- Postmenopausal Hormone Therapy and Risk of Idiopathic Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyBMJ, 2009
- Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ, 2008
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007
- Estrogen Plus Progestin and Risk of Venous ThrombosisJAMA, 2004
- Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement StudyAnnals of Internal Medicine, 2000
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994